Enright buys Zenas Biopharma (ZBIO) stock worth $2.25 million
PositiveFinancial Markets
Enright has made a significant investment by purchasing $2.25 million worth of stock in Zenas Biopharma. This move highlights confidence in the company's potential for growth and innovation in the biopharmaceutical sector. Such investments can lead to advancements in healthcare and potentially benefit patients, making it a noteworthy development in the industry.
— Curated by the World Pulse Now AI Editorial System